List of Tables
Table 1. Major Company of Immune DTaP Vaccine
Table 2. Major Company of Therapy DTaP Vaccine
Table 3. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2023) & (K Doses)
Table 5. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2023) & (US& Million)
Table 7. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share in Value by Type (2018-2023)
Table 8. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type (2018-2023) & (USD/Dose)
Table 9. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2024-2029) & (K Doses)
Table 10. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type (2024-2029) & (USD/Dose)
Table 14. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2023) & (K Doses)
Table 15. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses) by Type (2018-2023)
Table 17. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses) by Type (2018-2023)
Table 19. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses) by Type (2018-2023)
Table 21. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses) by Type (2018-2023)
Table 23. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Company (2018-2023) & (K Doses)
Table 25. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Share by Company (2018-2023)
Table 26. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Company (2018-2023)
Table 28. Global Market Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Company (2018-2023) & (USD/Dose)
Table 29. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
Table 33. Key Manufacturers Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2018-2023) & (K Doses)
Table 37. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Region (2018-2023)
Table 40. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 41. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2024-2029) & (K Doses)
Table 42. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2029)
Table 46. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) & (K Doses)
Table 48. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Application (2018-2023)
Table 51. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Application (2018-2023) & (USD/Dose)
Table 52. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2024-2029) & (K Doses)
Table 53. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Application (2024-2029) & (USD/Dose)
Table 57. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) (K Doses)
Table 58. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) (K Doses)
Table 60. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) (K Doses)
Table 62. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) (K Doses)
Table 64. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) (K Doses)
Table 66. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2018-2023) & (K Doses)
Table 68. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Country (2018-2023)
Table 71. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2024-2029) & (K Doses)
Table 72. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2018-2023) & (K Doses)
Table 76. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2024-2029) & (K Doses)
Table 80. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2018-2023) & (K Doses)
Table 84. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2024-2029) & (K Doses)
Table 88. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2018-2023) & (K Doses)
Table 92. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2024-2029) & (K Doses)
Table 96. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2018-2023) & (K Doses)
Table 100. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2024-2029) & (K Doses)
Table 104. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Sanofi Pasteur Company Information
Table 108. Sanofi Pasteur Introduction and Business Overview
Table 109. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 110. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 111. Sanofi Pasteur Recent Development
Table 112. GlaxoSmithKline Company Information
Table 113. GlaxoSmithKline Introduction and Business Overview
Table 114. GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 115. GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 116. GlaxoSmithKline Recent Development
Table 117. Protein Sciences Corporation Company Information
Table 118. Protein Sciences Corporation Introduction and Business Overview
Table 119. Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 120. Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 121. Protein Sciences Corporation Recent Development
Table 122. Novartis AG Company Information
Table 123. Novartis AG Introduction and Business Overview
Table 124. Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 125. Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 126. Novartis AG Recent Development
Table 127. Seqirus Company Information
Table 128. Seqirus Introduction and Business Overview
Table 129. Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 130. Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 131. Seqirus Recent Development
Table 132. Merck Sharp & Dohme Corp Company Information
Table 133. Merck Sharp & Dohme Corp Introduction and Business Overview
Table 134. Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 135. Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 136. Merck Sharp & Dohme Corp Recent Development
Table 137. Astellas Pharma US Company Information
Table 138. Astellas Pharma US Introduction and Business Overview
Table 139. Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 140. Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 141. Astellas Pharma US Recent Development
Table 142. Pfizer Inc Company Information
Table 143. Pfizer Inc Introduction and Business Overview
Table 144. Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 145. Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 146. Pfizer Inc Recent Development
Table 147. Johnson & Johnson Company Information
Table 148. Johnson & Johnson Introduction and Business Overview
Table 149. Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 150. Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 151. Johnson & Johnson Recent Development
Table 152. Lanzhou Institute of Biological Products Co., Ltd Company Information
Table 153. Lanzhou Institute of Biological Products Co., Ltd Introduction and Business Overview
Table 154. Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 155. Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 156. Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table 157. AstraZeneca Company Information
Table 158. AstraZeneca Introduction and Business Overview
Table 159. AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 160. AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 161. AstraZeneca Recent Development
Table 162. Emergent BioSolutions Inc Company Information
Table 163. Emergent BioSolutions Inc Introduction and Business Overview
Table 164. Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)
Table 165. Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product
Table 166. Emergent BioSolutions Inc Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Trends
Table 170. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Drivers
Table 171. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Challenges
Table 172. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Restraints
Table 173. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
Table 174. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Picture
Figure 2. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Status and Outlook (2018-2029) & (K Doses)
Figure 5. Product Picture of Immune DTaP Vaccine
Figure 6. Global Immune DTaP Vaccine Sales YoY Growth (2018-2029) & (K Doses)
Figure 7. Product Picture of Therapy DTaP Vaccine
Figure 8. Global Therapy DTaP Vaccine Sales YoY Growth (2018-2029) & (K Doses)
Figure 9. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue in 2022
Figure 23. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Adult
Figure 25. Global Adult Sales YoY Growth (2018-2029) & (K Doses)
Figure 26. Product Picture of Pediatric
Figure 27. Global Pediatric Sales YoY Growth (2018-2029) & (K Doses)
Figure 28. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application in 2022 & 2029
Figure 30. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturing Cost Structure
Figure 41. Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed